IASAX | JVMSX | IASAX / JVMSX | |
Total Expense Ratio | 1.35 | 1.25 | 108% |
Annual Report Gross Expense Ratio | 1.64 | 1.26 | 130% |
Fund Existence | 23 years | 13 years | - |
Gain YTD | -4.369 | -2.424 | 180% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 271M | 20.6B | 1% |
Annual Yield % from dividends | 1.42 | 0.46 | 309% |
Returns for 1 year | -2.88 | -8.45 | 34% |
Returns for 3 years | -23.74 | 4.66 | -509% |
Returns for 5 years | 22.65 | 50.94 | 44% |
Returns for 10 years | -21.36 | 27.80 | -77% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XBI | 78.04 | 0.69 | +0.89% |
SPDR® S&P Biotech ETF | |||
XBAP | 35.08 | 0.15 | +0.44% |
Innovator US Eq Acltd 9 Bfr ETFTM April | |||
MARW | 31.14 | 0.11 | +0.34% |
AllianzIM U.S. Large Cp Buffer20 Mar ETF | |||
DFSI | 37.11 | -0.01 | -0.02% |
Dimensional International Sstby Cr 1 ETF | |||
BFIX | 25.14 | -0.08 | -0.30% |
Build Bond Innovation ETF |